A Phase II Study of CART-ddBCMA for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma
ENROLLING
Trial ID:
NCT05396885 Protocol # :
22-533
Phase
II
Disease Sites
Multiple Myeloma
Principal Investigator
Frigault, Matt, J
Site Research Nurses
Gammon, Marilyn
Noyes, Sarah, M.
Weigel, Susan
Trial Description
Call 877-DF-TRIAL (877-338-7425) to learn more about this clinical trial, protocol #22-533
22-533